Adding radiotherapy to chemotherapy in advanced NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adding radiotherapy to chemotherapy in advanced NSCLC

Published:2017-11 Issue:11 Volume:18 Page:e645
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Brower Vicki

Publisher

Elsevier BV

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy;Coordination Chemistry Reviews;2024-12

2. Harnessing Hafnium‐Based Nanomaterials for Cancer Diagnosis and Therapy;Small;2023-04-08

3. Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation;Bioengineered;2022-03-01

4. SIRT6 through PI3K /Akt/ mTOR signaling pathway to enhance radiosensitivity of non‐Small cell lung cancer and inhibit tumor progression;IUBMB Life;2021-06-04

5. Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis;Cancers;2020-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3